MET receptor tyrosine kinase

scientific article

MET receptor tyrosine kinase is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.1097/01.JTO.0000361752.86918.09
P932PMC publication ID2846396
P698PubMed publication ID19861919

P50authorRavi SalgiaQ73567837
P2093author name stringLeonardo Faoro
Gustavo M Cervantes
Essam El-Hashani
P2860cites workThe MET receptor tyrosine kinase is a potential novel therapeutic target for head and neck squamous cell carcinomaQ30494514
Increased MET gene copy number negatively affects survival of surgically resected non-small-cell lung cancer patientsQ35926926
Downstream signalling and specific inhibition of c-MET/HGF pathway in small cell lung cancer: implications for tumour invasionQ36610910
c-Met and hepatocyte growth factor: potential as novel targets in cancer therapyQ36731520
Expression and mutational analysis of MET in human solid cancersQ36975055
A selective small molecule inhibitor of c-Met, PHA665752, inhibits tumorigenicity and angiogenesis in mouse lung cancer xenograftsQ40144642
Functional expression and mutations of c-Met and its therapeutic inhibition with SU11274 and small interfering RNA in non-small cell lung cancer.Q40453775
c-MET mutational analysis in small cell lung cancer: novel juxtamembrane domain mutations regulating cytoskeletal functionsQ40626106
Germline and somatic mutations in the tyrosine kinase domain of the MET proto-oncogene in papillary renal carcinomasQ45345804
Molecular cloning of a new transforming gene from a chemically transformed human cell line.Q45345810
P433issue11 Suppl 3
P304page(s)S1064-5
P577publication date2009-11-01
P1433published inJournal of Thoracic OncologyQ2448056
P1476titleMET receptor tyrosine kinase
P478volume4

Reverse relations

cites work (P2860)
Q37771888Molecular testing in lung cancer: the time is now.
Q90611396Tailoring subtractive cell biopanning to identify diffuse gastric adenocarcinoma-associated antigens via human scFv antibodies

Search more.